A Sleep Focused Parenting Intervention for Preschool Aged Children at Risk for ADHD (OASIS)

December 5, 2023 updated by: Heather Joseph, University of Pittsburgh

A Parent Behavioral Intervention Targeting Sleep Among Preschool Aged Children at Elevated Risk for Attention-Deficit/Hyperactivity Disorder (ADHD): A Pilot Effectiveness Trial in Pediatric Primary Care

The goal of this pilot clinical effectiveness trial is to compare a brief parent behavioral intervention (PBI) to a modified sleep focused PBI (SF-PBI) delivered by therapists in pediatric primary care for families of children 3-5 years old with sleep problems and early ADHD symptoms.

The main aims are to:

  • Demonstrate acceptability, feasibility, and appropriateness of the SF-PBI.
  • Examine change in sleep and ADHD symptoms among preschoolers with ADHD symptoms receiving SF-PBI compared to the brief PBI.

Study Overview

Detailed Description

Sleep problems may be one mechanism through which young children may be at risk for developing ADHD, although first line ADHD interventions, including parent behavioral interventions (PBIs), do not address sleep. Investigators will test a modified version of a PBI to target sleep disrupting behaviors for children 3-5 years old at elevated risk for ADHD. The intervention will be delivered by behavioral health therapists embedded in pediatric primary care to increase families' access to intervention. This pilot effectiveness trial is the first step towards developing an early intervention targeting sleep as a mechanism to reduce the prevalence, symptoms, and impairments associated with childhood ADHD.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • Recruiting
        • University of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 5 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Parent/Caregiver:

  • (1) Legal guardian is at least 18 years of age
  • (2) English speaking

Child:

  • (1) 3-5 years of age
  • (2) Caregiver report of 4 or more ADHD symptoms
  • (3) Caregiver report of one or more sleep problems
  • (4) English speaking.

Exclusion Criteria:

  • (1) Sleep interfering medical diagnoses (e.g., narcolepsy, obstructive sleep apnea)
  • (2) Severe neurodevelopmental disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Brief Parent Behavioral Intervention
A brief parent behavioral intervention with evidenced based strategies for treatment of ADHD.
PBI administered in pediatric primary care by an embedded therapist.
Experimental: Sleep-Focused Parent Behavioral Intervention
A modified version of the brief parent behavioral intervention that specifically targets sleep disrupting behaviors.
SF-PBI administered in pediatric primary care by an embedded therapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Acceptability
Time Frame: Post Intervention at approximately 4 months
Therapists and caregiver report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good acceptability.
Post Intervention at approximately 4 months
Intervention Appropriateness
Time Frame: Post Intervention at approximately 4 months
Therapists and caregiver report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good appropriateness.
Post Intervention at approximately 4 months
Intervention Feasibility
Time Frame: Post Intervention at approximately 4 months
Therapists and caregiver report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1-completely disagree to 5-completely agree, with scores greater than or equal to 16 indicating good feasibility.
Post Intervention at approximately 4 months
Problematic Sleep
Time Frame: Change from baseline up to 8 months
Using the Brief Child Sleep Questionnaire caregivers will report on their perception of child's sleep as problematic, rated 1 (Not at all) to 5 (A serious problem).
Change from baseline up to 8 months
ADHD Symptoms
Time Frame: Change from baseline up to 8 months
Using the 18-item ADHD Rating Scale-IV-Preschool Version caregivers will report on the child's ADHD symptoms. Symptoms are rated from 0 (Rarely) to 3 (Very Often).
Change from baseline up to 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nighttime Awakenings
Time Frame: Change from baseline up to 8 months
Caregivers will report how many times their child typically wakes during the night, using the Brief Child Sleep Questionnaire.
Change from baseline up to 8 months
Sleep Latency
Time Frame: Change from baseline up to 8 months
Sleep latency will be determined by using the caregiver report of how long it typically takes their child to fall asleep (number of minutes), using the Brief Child Sleep Questionnaire.
Change from baseline up to 8 months
Consistency of Bedtime Routine
Time Frame: Change from baseline up to 8 months
Caregivers will report the number of days, in a typical week, they regularly put their child to bed at the same time (within 15 minutes), using the Brief Child Sleep Questionnaire.
Change from baseline up to 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather M Joseph, DO, Assistant Professor of Psychiatry and Pediatrics, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2023

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

November 24, 2022

First Submitted That Met QC Criteria

January 4, 2023

First Posted (Actual)

January 13, 2023

Study Record Updates

Last Update Posted (Estimated)

December 6, 2023

Last Update Submitted That Met QC Criteria

December 5, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data collected during the trial will be shared, after deidentification, via the NIMH National Data Archive.

IPD Sharing Time Frame

Data will be shared upon publication or 1 year after the grant end date. Data will be available indefinitely.

IPD Sharing Access Criteria

Any NIMH NDA authorized users may request the data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep

Clinical Trials on Brief Parent Behavioral Intervention

3
Subscribe